Hepatocellular Carcinoma
Medicine & Life Sciences
100%
Sorafenib
Medicine & Life Sciences
64%
Hepacivirus
Medicine & Life Sciences
44%
Liver
Medicine & Life Sciences
38%
Chronic Hepatitis C
Medicine & Life Sciences
32%
Interferons
Medicine & Life Sciences
30%
Non-alcoholic Fatty Liver Disease
Medicine & Life Sciences
29%
Therapeutics
Medicine & Life Sciences
22%
Nakaoka, K. ,
Hashimoto, S. ,
Kawabe, N. ,
Kuzuya, T. ,
Yamada, S. ,
Sawaki, A. ,
Funasaka, K. ,
Nagasaka, M. ,
Nakagawa, Y. ,
Miyahara, R. ,
Shibata, T. ,
Tsukamoto, T. &
Hirooka, Y. ,
02-2022 ,
In: Clinical Journal of Gastroenterology. 15 ,
1 ,
p. 256-262 7 p. 研究成果: Article › 査読
Cushing Syndrome
100%
Pancreatic Neoplasms
79%
Adrenocorticotropic Hormone
23%
Gastrinoma
17%
Neuroendocrine Cells
15%
Yamamoto, T. ,
Imai, N. ,
Kuzuya, T. ,
Yokoyama, S. ,
Yamamoto, K. ,
Ito, T. ,
Ishizu, Y. ,
Honda, T. &
Ishigami, M. ,
2022 ,
In: Nutrition and Cancer. 74 ,
9 ,
p. 3118-3127 10 p. 研究成果: Article › 査読
lenvatinib
100%
Body Composition
59%
Treatment Failure
58%
Hepatocellular Carcinoma
48%
Retrospective Studies
40%
Kuzuya, T. ,
Kawabe, N. ,
Hashimoto, S. ,
Funasaka, K. ,
Nagasaka, M. ,
Nakagawa, Y. ,
Miyahara, R. ,
Shibata, T. ,
Takahara, T. ,
Kato, Y. ,
Sugioka, A. &
Hirooka, Y. ,
04-2022 ,
In: Anticancer research. 42 ,
4 ,
p. 1905-1910 6 p. 研究成果: Article › 査読
ramucirumab
100%
atezolizumab
97%
Bevacizumab
68%
Hepatocellular Carcinoma
49%
alpha-Fetoproteins
27%
Kuzuya, T. ,
Kawabe, N. ,
Hashimoto, S. ,
Miyahara, R. ,
Sawaki, A. ,
Nakano, T. ,
Nakaoka, K. ,
Tanaka, H. ,
Miyachi, Y. ,
Mii, A. ,
Kamejima, S. ,
Takahara, T. ,
Kato, Y. ,
Sugioka, A. &
Hirooka, Y. ,
01-01-2022 ,
In: Oncology (Switzerland). 100 ,
1 ,
p. 12-21 10 p. 研究成果: Article › 査読
atezolizumab
100%
Bevacizumab
70%
alpha-Fetoproteins
69%
Hepatocellular Carcinoma
50%
Prothrombin
18%
Ozawa, N. ,
Sato, K. ,
Sugimura, A. ,
Maki, S. ,
Tanaka, T. ,
Yamamoto, K. ,
Ito, T. ,
Ishizu, Y. ,
Kuzuya, T. ,
Honda, T. ,
Ishigami, M. ,
Fujishiro, M. ,
Ishikawa, T. &
Ando, S. ,
2022 ,
In: Nagoya journal of medical science. 84 ,
4 ,
p. 857-864 8 p. 研究成果: Article › 査読
Non-alcoholic Fatty Liver Disease
100%
Aspartate Aminotransferases
94%
Alanine Transaminase
90%
Uncertainty
85%
Health Personnel
8%